CA-XRAN-FOUNDATION
27.2.2017 08:03:01 CET | Business Wire | Press release
The xRAN Foundation, a consortium dedicated to promoting a software-based, extensible Radio Access Network (xRAN) and to standardizing critical elements of the xRAN architecture, today announced that Verizon, a global leader of innovative mobile communications, technology and infrastructure and Ranzure, a provider of flexible, virtualized, cloud-based 4G/5G RAN solutions, have joined the xRAN Foundation. In addition to these key new members, the xRAN Foundation has announced a collaboration with M-CORD , the open source project reinventing network access to bring datacenter economics and cloud agility to service providers’ central offices.
“A network architecture that provides a robust, interactive abstraction layer between applications and RAN infrastructure fits very well with our vision and goals. We believe this approach creates opportunities to increase the efficiency of our network and improve the quality of experience for our subscribers,” said Adam Koeppe, Vice President, Network Technology Planning at Verizon. “The xRAN Foundation has demonstrated the feasibility of a decoupled approach. The combination of standardized north-bound and south-bound interfaces allows the development of applications that can intelligently interact with the RAN infrastructure in a way that has never been possible before. We are excited to join the xRAN Foundation and plan to actively evaluate solutions that support xRAN interfaces and architecture.”
“For an efficient delivery of next generation mobile services, such as AR, IoT and industrial robotics, a new more flexible software-based and hardware independent RAN architecture is required. The xRAN approach will offer us real time programmability and control of our RAN infrastructure to dynamically adapt to our customers' needs,” said Bruno Jacobfeuerborn, CTO, Deutsche Telekom. “We are excited to see xRAN and CORD Project join forces to drive the development of this approach.”
Formally formed in October of 2016 by AT&T, Deutsche Telekom, SK Telecom, Intel Corporation, Texas Instruments, Radisys, Aricent and Stanford University, the xRAN Foundation is a consortium dedicated to promoting a software-based, extensible Radio Access Network (xRAN) and to standardizing critical elements of the xRAN architecture. The xRAN architecture transforms today’s static, highly-proprietary RAN infrastructure into an extensible, software-based service delivery platform capable of rapidly responding to changing user, application and business needs.
The xRAN Foundation is holding a panel discussion event at Mobile World Congress 2017 in Barcelona on Tuesday February 28th at noon on the Deutsche Telekom main presentation stage in Hall 3. The event will include an introduction presentation by Deutche Telekom CTO, Bruno Jacobfeuerborn, followed by a panel discussion moderated by Petr Ledl, Head of Deutsche Telekom 5G:haus. The panel includes Dr. Sachi Katti, Stanford University, Dr. Kim Larsen, Technology Economics & Transformation (TET) & AI Technology Architecture & Innovation (TAI) Group Technology at Deutsche Telekom, Gordon Mansfield, Vice President RAN & Device Design at AT&T, and Caroline Chan, VP and GM, 5G Infrastructure Division, Network Platform Group, at Intel.
A multi-vendor demonstration of the xRAN controller, featuring the Intel + Radisys and the Texas Instruments + Aricent reference platforms, will be hosted during Mobile World Congress. Register for a demo here: http://xran.org/mwc
About xRAN Foundation
The xRAN Foundation was formed to develop, standardize and promote an open alternative to the traditionally closed, hardware-based RAN architecture. xRAN fundamentally advances RAN architecture in three areas – decouples the RAN control plane from the user plane, builds a modular eNB software stack that operates on common-off-the-shelf (COTS) hardware and publishes open north- and south-bound interfaces to the industry. For more information about xRAN Foundation membership go to xran.org/membership or email info@xran.org . For more information on xRAN architecture, download the xRAN Architecture white paper . To schedule a briefing with xRAN member representatives at Mobile World Congress in Barcelona, please contact pr@xran.org .
View source version on businesswire.com: http://www.businesswire.com/news/home/20170226005155/en/
Contact:
xRAN Foundation
Rod Stuhlmuller
rod@xran.org
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom